CATEGORIES

Pharmaceutics

LATEST

TRENDING

EDITORS CHOICE

Uqora Develops the First Non-Antibiotic Treatment Option for UTIs

The new drug program aims to decrease the amount of UTIs that would otherwise require antibiotic intervention.

When is a Vaccine not a Vaccine?

Simple question and in theory, the answer is as simple. A vaccine is a vaccine when it conforms to the properties we assign historically...

Lilly commits Insulin Value Program, With $35 Copay Card

Anyone with commercial insurance, and those without insurance at all, can continue filling their monthly prescription of Lilly insulins for $35 through this program.

FDA approves Ready-to-Use Ephedrine Injection, Emerphed™

Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)